Tormere Analytics

>/

Overview Market News Stock Research Charts Portfolio Lab Options Lab Calculators Watchlist

Privacy Policy Terms of Service

ZIOP: Insider Trading, Congress Trades & Research | Tormere

ZIOP

download financials (.py)

ZIOP

Market Cap

—

Sector

—

Industry

—

Beta (raw)

—

Insufficient price history

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Price / TTM revenue

P/B

—

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

4

recent articles

No Form 4 transactions on record.

Recent News

Net Worth Update: Senator Mark R. Warner Lost an Estimated $856.9K in the Stock Market Last Month

Quiver Quantitative · 2026-08-02

Net Worth Update: Senator Mark R. Warner Made an Estimated $2.1M in the Stock Market Last Month

Quiver Quantitative · 2026-05-24

Ziopharm Rebrands As Alaunos Therapeutics

Yahoo Finance · 2022-01-26

Is Ziopharm Oncology Inc. a Buy?

The Motley Fool · 2018-06-17

Informational purposes only, not investment advice.

ZIOP (ZIOP)

tormere.com/research/ZIOP · generated 2026-10-28

General Information

Price—

Change—

Market Cap—

Sector—

Industry—

Exchange—

Beta (raw, monthly vs SPY)—

Signals

Insider Velocity—

Congress Trades (90d)—

Short Volume—

Conviction Score—

Recent News

Net Worth Update: Senator Mark R. Warner Lost an Estimated $856.9K in the Stock Market Last Month — Quiver Quantitative · 2026-08-02
Net Worth Update: Senator Mark R. Warner Made an Estimated $2.1M in the Stock Market Last Month — Quiver Quantitative · 2026-05-24
Ziopharm Rebrands As Alaunos Therapeutics — Yahoo Finance · 2022-01-26
Is Ziopharm Oncology Inc. a Buy? — The Motley Fool · 2018-06-17

Tormere — informational purposes only, not investment advice.

Factor Profile

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →